drugset / Trial / NCT00949884

Olmesartan Comparison to Losartan in Hypertensive Subjects

NCT00949884

Phase 4 Completed 941 enrolled Daiichi Sankyo
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will evaluate the efficacy and safety of the FDA approved blood pressure medication olmesartan medoxomil compared to the FDA approved medication losartan potassium.

Timeline

Start
2009-08
Primary completion
2010-01
Completion
2010-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Losartan Other / unclassified 100 mg Oral
Subject Olmesartan medoxomil Unknown 40 mg Oral

Indications